期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | NEUROSURGICAL REVIEW LetPub Score 6.3
50 ratings
Rate
Reputation 7.6 Influence 4.9 Speed 7.0 | ||||||||||||||||||||
期刊簡稱 | NEUROSURG REV | ||||||||||||||||||||
ISSN | 0344-5607 | ||||||||||||||||||||
E-ISSN | 1437-2320 | ||||||||||||||||||||
h-index | 52 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 4.00%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | https://www.springer.com/10143 | ||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/nrev | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Springer Berlin Heidelberg | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | GERMANY | ||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||
創刊年 | 1978 | ||||||||||||||||||||
每年文章數 | 288每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 25.91% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0344-5607%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[NEUROSURGICAL REVIEW] 的評論 | 撰寫評論 |
作者: 坠星卫利 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-23 08:38:17 評論於 Support universal communication(0) 讚! | 坠星卫利 |
作者: 仙灵飞槐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-25 18:14:48 評論於 Review speed: 1.0 | Submission acceptance rate: 50.0 Focused research area: Cerebrovascular disease Experience sharing: I have reviewed three papers for this journal in 2023, all from Japanese scholars. Two were accepted for publication and one was rejected, which is relatively good(0) 讚! | 仙灵飞槐 |
作者: 寂灭永顺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-16 14:22:35 評論於 Hello teacher, I would like to ask, if Reviewer 1 has no comments and Reviewer 2 only gave 3 suggestions, is it likely that I will be accepted if I address all of Reviewer 2's suggestions? It has been 12 days since the revision, and only one review has come back. Do you think I will be accepted?(0) 讚! | 寂灭永顺 |
作者: 重阳绮丽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-27 10:45:44 評論於 Teacher Wang's advice is very insightful(0) 讚! | 重阳绮丽 |
作者: 巴蜀秀玲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-02 13:38:22 評論於 Where can I check the status of manuscript submission? Urgent request(0) 讚! | 巴蜀秀玲 |
作者: 九阳凯乐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-13 19:20:18 評論於 Endnotes can be set up and sorted alphabetically(0) 讚! | 九阳凯乐 |
作者: Michelle Bessie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-12 08:27:56 評論於 Have you solved the same problem?(0) 讚! | Michelle Bessie |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 16:20:04 評論於 ORCID is an Open Researcher and Contributor ID. An ORCID ID is a unique and persistent academic identity for contributors, helping to distinguish authors from other researchers and record all their related research activities. It is necessary to log into each author's account and make the association in the account information(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 10:39:04 評論於 Due to the many factors that can affect the efficacy of animal experiments or clinical treatments, unless the results show a clear synergistic effect is produced that significantly increases the effectiveness beyond the sum of each drug, it is generally referred to as an enhancement effect(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 19:19:23 評論於 How to determine whether two drugs have a synergistic or additive effect?(0) 讚! | 龙鳞孝礼 |
作者: 魂魄彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 12:22:41 評論於 How to add ORCID iDs to articles that have been published without them?(0) 讚! | 魂魄彦露 |
作者: 名轩三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-26 11:04:42 評論於 Could you please tell me where to find the reference endnote format for this magazine? My submission was sent back stating that the references need to be in the required format(0) 讚! | 名轩三岁啦 |
作者: 李医学僧 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2021-10-28 09:44:52 評論於 Neurosurgical Review is a remarkable journal. It takes only one month for the submission process, and after minor revisions, the paper is accepted directly.(0) 讚! | 李医学僧 |
作者: 上清雨青 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-31 22:27:58 評論於 This magazine supports mutual communication among big shots(0) 讚! | 上清雨青 |
作者: 七伤正雅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-09-19 21:19:52 評論於 Is it still easy to be rejected after the major overhaul?(0) 讚! | 七伤正雅 |
作者: 是依柔吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-07-23 22:45:25 評論於 Submitted a clinical review on 6.11, deadline on 7.20 for external review. Rejected on 7.23. A sad story, but some of the reviewers' comments were still very constructive(0) 讚! | 是依柔吖 |
作者: 绿松小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-07-20 21:44:17 評論於 So slow(0) 讚! | 绿松小公主 |
作者: 白真来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-07-03 19:55:31 評論於 Review Speed: 2.0 | Submission Success Rate: 50.0 Experience sharing: #Spine# is a quarterly journal with few articles per year. I only realized this after submitting my manuscript. The review process is quite efficient and the feedback is very constructive(0) 讚! | 白真来了 |
作者: 雅懿酱吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-06-10 20:02:17 評論於 Have you made any progress?(0) 讚! | 雅懿酱吖 |
作者: Ann Wheatley 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-05-28 08:42:05 評論於 The submission is shown once a week, is this normal?(0) 讚! | Ann Wheatley |
作者: Natividad Lee 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-03-09 08:49:46 評論於 Review Speed: 3.0 | Submission Acceptance Rate: 50.0 Experience Sharing: A very good journal, with excellent editors and reviewers providing constructive feedback and fast review speeds(0) 讚! | Natividad Lee |
作者: 落雁晓阳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-09-04 20:10:11 評論於 The article by wanglong6789 upstairs is from Professor Sanboshi Yoshinori, amazing! Admire!(0) 讚! | 落雁晓阳 |
作者: 震雷微澜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-08-11 15:21:54 評論於 Review speed: 2.0 | Submission hit rate: 95.0 Experience sharing: The article we submitted about bridging treatment for complex arterial aneurysms caused by cerebrovascular disease is about very difficult aneurysm surgeries, which are relatively common! It took about a month and a half to revise, with feedback from three editors: the first one provided 7 questions, both big and small, and very constructive suggestions; the second provided just one question; the third did not provide any feedback. All editors gave very high evaluations of the article, and the editorial department also mentioned that the chances of publication are very high. After revising in six days, the article was accepted on the third day, and is currently waiting to be published online. The specific timetable is as follows: 12 Aug 2016 Editor Decision - Accept 10 Aug 2016 AU - Revised PDF Built by Author 04 Aug 2016 Editor Decision - Major Revision 17 Jun 2016 AU - Author Submission 17 Jun 2016 AU - Original PDF Built by Author Hope this is helpful for everyone's submissions!(0) 讚! | 震雷微澜 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us